Despite challenging market conditions, Germany’s biotech companies raised a total of 1.8 billion euros in capital in 2025—a 5 percent decrease from the previous year, when the total stood at 1.9 billion euros. Venture capital investments also declined in 2025 compared to the previous year, falling f...
